Amalgamated Financial’s Olema Pharmaceuticals OLMA Stock Holding History

Amalgamated Financial’s Portfolio OLMA Stock Details OLMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$15K	Buy	+3,542	New	+$19.5K	﹤0.01%	2819

Other funds holding OLMA

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Amalgamated Financial's OLMA Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Olema Pharmaceuticals (OLMA) in Q1 2022: 3,542 shares worth $15K. The stake represents ﹤0.01% of the portfolio and ranks #2819 among its holdings.

91 funds tracked by Wall St. Rank hold OLMA as of Q1 2022.

Amalgamated Financial held 3,542 shares of Olema Pharmaceuticals worth $15K as of Q1 2022.
Olema Pharmaceuticals was a new Amalgamated Financial position in Q1 2022.
Olema Pharmaceuticals made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2819 holding.
91 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.